SCHEMBL13115154

SCHEMBL13115154

CC(C)C(CO)n1ccc2c(NC(=O)[C@@H](C)c3ccc(Cl)cc3)cccc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 6/20 0.56
MAPT P10636 4/20 0.41
TP53 P04637 1/20 0.41
KMT2A Q03164 2/20 0.38
NR3C2 P08235 1/20 0.37
FFAR2 O15552 1/20 0.36
CRHBP P24387 1/20 0.36
RAB9A P51151 1/20 0.36
CRHR2 Q13324 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SHMT2 P34897 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
GPR139 Q6DWJ6 2/20 0.35
PTGES O14684 1/20 0.35
LMNA P02545 1/20 0.35
KCNQ2 O43526 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591590 1.00 P2RX7 (0.56) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1590078 1.00 P2RX7 (0.56) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1591586 1.00 P2RX7 (0.56) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1590073 1.00 P2RX7 (0.56) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1590076 1.00 P2RX7 (0.56) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1591343 0.90 P2RX7 (0.52) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL12702943 0.86 P2RX7 (0.46) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1590085 0.86 P2RX7 (0.43) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1590507 0.86 P2RX7 (0.46) P2RX7MAPTTP53KMT2ANR3C2
SCHEMBL1590087 0.86 P2RX7 (0.43) P2RX7MAPTTP53KMT2ANR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof P2RX7, P2RX3, P2RX2 P2RX7 1/4885MAPT 4477/4885TP53 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.